[go: up one dir, main page]

GB0230086D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0230086D0
GB0230086D0 GB0230086A GB0230086A GB0230086D0 GB 0230086 D0 GB0230086 D0 GB 0230086D0 GB 0230086 A GB0230086 A GB 0230086A GB 0230086 A GB0230086 A GB 0230086A GB 0230086 D0 GB0230086 D0 GB 0230086D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0230086A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0230086A priority Critical patent/GB0230086D0/en
Publication of GB0230086D0 publication Critical patent/GB0230086D0/en
Priority to TW096130334A priority patent/TW200813014A/en
Priority to TW092106024A priority patent/TWI324597B/en
Priority to HK05103509.3A priority patent/HK1070888B/en
Priority to CA2479642A priority patent/CA2479642C/en
Priority to PT03710015T priority patent/PT1487806E/en
Priority to NZ535014A priority patent/NZ535014A/en
Priority to US10/508,675 priority patent/US20050215574A1/en
Priority to PL372889A priority patent/PL214880B1/en
Priority to KR1020047015473A priority patent/KR101006947B1/en
Priority to DK03710015.3T priority patent/DK1487806T3/en
Priority to EP03710015A priority patent/EP1487806B1/en
Priority to IL16413503A priority patent/IL164135A0/en
Priority to UA20041008762A priority patent/UA78302C2/en
Priority to ES03710015T priority patent/ES2346135T3/en
Priority to PCT/GB2003/001306 priority patent/WO2003082831A1/en
Priority to RU2004131683/04A priority patent/RU2345989C2/en
Priority to SI200331852T priority patent/SI1487806T1/en
Priority to HK05111553.1A priority patent/HK1079521B/en
Priority to AT03710015T priority patent/ATE473215T1/en
Priority to BR0308670-4A priority patent/BR0308670A/en
Priority to MXPA04009486A priority patent/MXPA04009486A/en
Priority to DE60333262T priority patent/DE60333262D1/en
Priority to CNB038117398A priority patent/CN100439344C/en
Priority to JP2003580299A priority patent/JP3891493B2/en
Priority to MYPI20031118A priority patent/MY158054A/en
Priority to AU2003214443A priority patent/AU2003214443B8/en
Priority to ARP030101122A priority patent/AR039203A1/en
Priority to UY27742A priority patent/UY27742A1/en
Priority to SA03240080A priority patent/SA03240080B1/en
Priority to IL164135A priority patent/IL164135A/en
Priority to IS7469A priority patent/IS2855B/en
Priority to NO20044325A priority patent/NO329542B1/en
Priority to JP2006102765A priority patent/JP2006249093A/en
Priority to US12/147,250 priority patent/US20080269487A1/en
Priority to US12/706,675 priority patent/US8399667B2/en
Priority to CY20101100824T priority patent/CY1111039T1/en
Priority to US13/608,092 priority patent/US20130005727A1/en
Ceased legal-status Critical Current

Links

GB0230086A 2002-03-28 2002-12-24 Compounds Ceased GB0230086D0 (en)

Priority Applications (38)

Application Number Priority Date Filing Date Title
GB0230086A GB0230086D0 (en) 2002-12-24 2002-12-24 Compounds
TW096130334A TW200813014A (en) 2002-03-28 2003-03-19 Quinazoline derivatives
TW092106024A TWI324597B (en) 2002-03-28 2003-03-19 Quinazoline derivatives
AU2003214443A AU2003214443B8 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
HK05111553.1A HK1079521B (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
BR0308670-4A BR0308670A (en) 2002-03-28 2003-03-26 Quinazoline derivative or a pharmaceutically acceptable salt thereof, process for preparing it, pharmaceutical composition, use of said derivative or salt thereof, method for producing an antiproliferative effect on a warm-blooded animal in need of such treatment, and , compound or a salt thereof.
PT03710015T PT1487806E (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
NZ535014A NZ535014A (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
US10/508,675 US20050215574A1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
PL372889A PL214880B1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
KR1020047015473A KR101006947B1 (en) 2002-03-28 2003-03-26 4-anilinoquinazoline derivatives as antiproliferative agents
DK03710015.3T DK1487806T3 (en) 2002-03-28 2003-03-26 4-aniline quinazoline derivatives as antiproliferative agents
EP03710015A EP1487806B1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
IL16413503A IL164135A0 (en) 2002-03-28 2003-03-26 4-Anilino quinazoline derivatives as antirpoliferative agents
UA20041008762A UA78302C2 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
ES03710015T ES2346135T3 (en) 2002-03-28 2003-03-26 DERIVATIVES OF 4-ANILINO QUINAZOLINA AS ANTIPROLIFERATIVE AGENTS.
PCT/GB2003/001306 WO2003082831A1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
RU2004131683/04A RU2345989C2 (en) 2002-03-28 2003-03-26 Derivatives of 4-anilino-benzodiazine, method of obtaining them (versions) pharmaceutical composition, method of inhibiting their proliferative action and method of treating cancer in warm-blooded animal
SI200331852T SI1487806T1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
HK05103509.3A HK1070888B (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
AT03710015T ATE473215T1 (en) 2002-03-28 2003-03-26 4-ANILINEQUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE ACTIVE INGREDIENTS
CA2479642A CA2479642C (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
MXPA04009486A MXPA04009486A (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents.
DE60333262T DE60333262D1 (en) 2002-03-28 2003-03-26 4-anilinchinazolinderivate als antiproliferative wirkstoffe
CNB038117398A CN100439344C (en) 2002-03-28 2003-03-26 4-Anilinoquinazoline derivatives as antiproliferative agents
JP2003580299A JP3891493B2 (en) 2002-03-28 2003-03-26 4-anilinoquinazoline derivatives as antitumor agents
MYPI20031118A MY158054A (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
UY27742A UY27742A1 (en) 2002-03-28 2003-03-28 QUINAZOLINE DERIVATIVES
ARP030101122A AR039203A1 (en) 2002-03-28 2003-03-28 QUINAZOLINE DERIVATIVES
SA03240080A SA03240080B1 (en) 2002-03-28 2003-04-16 4-ANILINO QUINAZOLINE derivatives AS ANTIPROLIFERATIVES AGENTS
IL164135A IL164135A (en) 2002-03-28 2004-09-19 4-anilino quinazoline derivatives as antiproliferative agents, process for their preparation, pharmaceutical compositions containing such derivatives and use thereof for the preparation of medicaments for the treatment of cancer
IS7469A IS2855B (en) 2002-03-28 2004-09-24 4-anilinoquinazoline derivatives as a propagating agent
NO20044325A NO329542B1 (en) 2002-03-28 2004-10-12 4-Anilinoquinazoline Derivatives, Methods for Preparing Such, Pharmaceutical Preparations Containing Such, Such Compounds for Use as a Medication, and Use of Such Compounds for the Preparation of Medication for the Treatment of Disease
JP2006102765A JP2006249093A (en) 2002-03-28 2006-04-04 4-anilinoquinazoline derivative as antineoplastic agent
US12/147,250 US20080269487A1 (en) 2002-03-28 2008-06-26 4-anilino quinazoline derivatives as antiproliferative agents
US12/706,675 US8399667B2 (en) 2002-03-28 2010-02-16 4-anilino quinazoline derivatives as antiproliferative agents
CY20101100824T CY1111039T1 (en) 2002-03-28 2010-09-09 4-ANILINO KINAZOLIN DERIVATIVE AS ANTI-COLLAPABLE FACTORS
US13/608,092 US20130005727A1 (en) 2002-03-28 2012-09-10 Quinazoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0230086A GB0230086D0 (en) 2002-12-24 2002-12-24 Compounds

Publications (1)

Publication Number Publication Date
GB0230086D0 true GB0230086D0 (en) 2003-01-29

Family

ID=9950371

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0230086A Ceased GB0230086D0 (en) 2002-03-28 2002-12-24 Compounds

Country Status (1)

Country Link
GB (1) GB0230086D0 (en)

Similar Documents

Publication Publication Date Title
GB0212785D0 (en) Compounds
EP1558585A4 (en) Neurologically-active compounds
GB0209022D0 (en) Compounds
GB0200283D0 (en) Compounds
AU2003216859A8 (en) Amidoacetonitrile compounds
GB0210762D0 (en) Compounds
GB0211418D0 (en) Compounds
GB0207323D0 (en) Compounds
GB0212399D0 (en) Compounds
GB0203778D0 (en) Compounds
GB0213011D0 (en) Compounds
GB0213122D0 (en) Compounds
GB0209244D0 (en) Compounds
AU2003275480A8 (en) Compounds
GB0203811D0 (en) Compounds
GB0206981D0 (en) Compounds
GB0203776D0 (en) Compounds
GB0210513D0 (en) Compounds
GB0204065D0 (en) Compounds
GB0204721D0 (en) Compounds
GB0204784D0 (en) Compounds
GB0206892D0 (en) Compounds
GB0206924D0 (en) Compounds
GB0203812D0 (en) Compounds
GB0207270D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)